ATANASIO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 127
EU - Europa 122
AS - Asia 29
SA - Sud America 2
Totale 280
Nazione #
US - Stati Uniti d'America 127
RU - Federazione Russa 52
IT - Italia 37
HK - Hong Kong 9
SG - Singapore 8
CN - Cina 7
FI - Finlandia 7
CH - Svizzera 6
IE - Irlanda 6
SE - Svezia 6
DE - Germania 4
NL - Olanda 3
AR - Argentina 2
IN - India 2
JO - Giordania 2
TW - Taiwan 1
UA - Ucraina 1
Totale 280
Città #
Santa Clara 69
Fairfield 7
Hong Kong 7
Bern 6
Chandler 6
Dublin 6
Helsinki 6
Singapore 6
Ashburn 5
Houston 5
Napoli 4
Woodbridge 4
Florence 3
Altamura 2
Cambridge 2
Chengdu 2
Cipolletti 2
Falkenstein 2
Lawrence 2
Lugo 2
Maranello 2
Milan 2
Modena 2
Mumbai 2
Pisa 2
Rimini 2
Rome 2
San Giovanni Valdarno 2
Sant'elpidio A Mare 2
Wilmington 2
Abenberg 1
Ann Arbor 1
Beijing 1
Boardman 1
Boston 1
Bremen 1
Buffalo 1
Caronno Pertusella 1
Catanzaro 1
Fiesole 1
Hangzhou 1
Jacksonville 1
Lappeenranta 1
Leawood 1
Monteriggioni 1
Moscow 1
Naples 1
New Taipei City 1
Princeton 1
Seattle 1
Specchia 1
Washington 1
Totale 190
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 131
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 64
CALR mutation burden in essential thrombocythemia and disease outcome 63
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience 30
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib 2
Totale 290
Categoria #
all - tutte 1.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 21 8 2 0 0 4 0 1 2 0
2021/202215 0 0 0 1 3 0 0 0 1 0 5 5
2022/202333 2 7 1 2 1 5 2 0 3 4 0 6
2023/202433 0 3 4 2 1 4 0 8 0 6 2 3
2024/2025171 5 22 9 36 60 39 0 0 0 0 0 0
Totale 290